Your browser doesn't support javascript.
loading
Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex.
Tang, Juanjie; Grubbs, Gabrielle; Lee, Youri; Huang, Chang; Ravichandran, Supriya; Forgacs, David; Golding, Hana; Ross, Ted M; Khurana, Surender.
Afiliación
  • Tang J; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, Maryland, USA, 20993.
  • Grubbs G; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, Maryland, USA, 20993.
  • Lee Y; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, Maryland, USA, 20993.
  • Huang C; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, Maryland, USA, 20993.
  • Ravichandran S; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, Maryland, USA, 20993.
  • Forgacs D; Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA, 30602.
  • Golding H; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, Maryland, USA, 20993.
  • Ross TM; Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA, 30602; Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA, 30602.
  • Khurana S; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, Maryland, USA, 20993. Electronic address: Surender.Khurana@fda.hhs.gov.
EBioMedicine ; 74: 103748, 2021 Dec.
Article en En | MEDLINE | ID: mdl-34902788

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / Glicoproteína de la Espiga del Coronavirus / SARS-CoV-2 / Vacuna BNT162 / Vacuna nCoV-2019 mRNA-1273 / Afinidad de Anticuerpos Límite: Female / Humans / Male Idioma: En Revista: EBioMedicine Año: 2021 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / Glicoproteína de la Espiga del Coronavirus / SARS-CoV-2 / Vacuna BNT162 / Vacuna nCoV-2019 mRNA-1273 / Afinidad de Anticuerpos Límite: Female / Humans / Male Idioma: En Revista: EBioMedicine Año: 2021 Tipo del documento: Article